Who owns Enlivex Therapeutics Ltd?
- Ticker: ENLV
- CUSIP Number: m4130y106
Tip: Access positions for across all investors
Analyze quarterly positions in Enlivex Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Enlivex Therapeutics stock
Who bought or sold Enlivex Therapeutics Ltd this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 2.2M | $2.6M | 3% | Dec 2024 |
|
| Millennium Management | 634k | $742k | 100% | Dec 2024 |
|
| Morgan Stanley | 270k | $316k | 10% | Dec 2024 |
|
| Renaissance Technologies | 159k | $186k | 113% | Dec 2024 |
|
| Sigma Investment Counselors | 28k | $33k | -7% | Dec 2024 |
|
| Two Sigma Securities | 22k | $26k | 100% | Dec 2024 |
|
| Citadel Advisors | 21k | $25k | -12% | Dec 2024 |
|
| Hrt Financial | 17k | $19k | 100% | Dec 2024 |
|
| Jane Street | 13k | $15k | 100% | Dec 2024 |
|
| Susquehanna International | 11k | $13k | 100% | Dec 2024 |
|
| Geode Capital Management | 10k | $12k | 0% | Dec 2024 |
|
| ARS Wealth Advisors Group | 10k | $12k | 100% | Dec 2024 |
|
| Wells Fargo & Company | 9.2k | $11k | 0% | Dec 2024 |
|
| Signature | 5.0k | $5.9k | 67% | Dec 2024 |
|
| Simplex Trading | 3.4k | $3.0k | 100% | Dec 2024 |
|
| Jpmorgan Chase & Co | 2.6k | $3.0k | 41% | Dec 2024 |
|
| Steward Partners Investment Advisory | 2.5k | $2.9k | -17% | Dec 2024 |
|
| Bank of America Corporation | 1.1k | $1.2k | 627% | Dec 2024 |
|
| SRS Capital Advisors | 1.0k | $1.2k | 65% | Dec 2024 |
|
| Activest Wealth Management | 1.0k | $1.2k | 0% | Dec 2024 |
|
| BFSG | 1.0k | $1.2k | 100% | Dec 2024 |
|
| Advisor Group Holdings | 709.00 | $1.0k | 77% | Dec 2024 |
|
| Spire Wealth Management | 500.00 | $585.000000 | 100% | Dec 2024 |
|
| Red Tortoise | 150.00 | $175.995000 | 0% | Dec 2024 |
|
| UBS Group | 16.00 | $19.000000 | -100% | Dec 2024 |
|
Who sold out of Enlivex Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| XTX Topco | Sep 2024 | 23k | $38k |
| Goldman Sachs Group | Sep 2024 | 14k | $23k |
| Group One Trading | Sep 2024 | 5.7k | $9.6k |